Therapeutic Area Focus

EmVenio offers a proven and innovative approach to make localized Phase I, II, III, and IV clinical trials easily accessible to underrepresented communities.

At EmVenio, our focus is on addressing the most critical needs in the clinical trial industry and population health. Presently, we concentrate on the following therapeutic areas and indications, and are continuously expanding our capabilities to support additional areas and adjacencies.

EmVenio concentrates its efforts on these therapeutic areas:

Cardiology
  • Atrial fibrillation (AFib)
  • Hyperlipidemia
  • Lipid Lowering agents to prevent Atherosclerotic cardiovascular disease (ASCVD)
Dermatology
  • Atopic Dermatitis
  • Acne
Gastrointestinal
  • Gastroesphageal reflux disease (GERD)
  • Gastritis
  • Irritable bowel syndrome (IBS)
Infectious Disease
  • COVID-19
  • Flu
  • Respiratory syncytial virus (RSV)
  • Pneumococcal Disease
  • Pertussis
Metabolic / Immunology
  • Obesity
  • Diabetes Mellitus
  • Hypertension
  • Allergy
  • Hyperlipidemia
  • Metabolic dysfunction-associated steatotic liver disease (MASLD) and Metabolic dysfunction-associated steatohepatitis (MASH)
Nephrology
  • Chronic Kidney
Neurology
  • Alzheimer’s Disease
  • Mild Cognitive Impairment
  • Parkinson’s Disease
  • Headache – migraine, cluster, and tension
Respiratory
  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Respiratory Infection testing
Women’s Health
  • Contraception
  • Uterine Fibroids
  • Hot Flashes
  • Endometriosis
  • Osteoporosis
  • Female Sexual Arousal Disorder
In-Vitro Diagnostics
  • Across Therapeutic Areas

Our sites and clinical staff are fully equipped with all the necessary resources to conduct trials effectively. Sites can be  fully customized to suit your clinical trials, supporting a full range of protocol procedures. They are supported by a proficient team of experienced medical, regulatory, and operational specialists, and we leverage their collective expertise to ensure the success of your study.